|
Name |
Stemphol
|
Molecular Formula | C15H24O2 | |
IUPAC Name* |
2-butyl-5-pentylbenzene-1,3-diol
|
|
SMILES |
CCCCCC1=CC(=C(C(=C1)O)CCCC)O
|
|
InChI |
InChI=1S/C15H24O2/c1-3-5-7-8-12-10-14(16)13(9-6-4-2)15(17)11-12/h10-11,16-17H,3-9H2,1-2H3
|
|
InChIKey |
CZZVTNRWOQFMEU-UHFFFAOYSA-N
|
|
Synonyms |
Stemphol; 2-butyl-5-pentylbenzene-1,3-diol; 70680-20-5; 2-butyl-5-pentylresorcinol; 50982-33-7; 2(or 5)-Butyl-5(or 2)-phenyl-1,3-benzenediol; SCHEMBL18782422; DTXSID10198982; CHEBI:182211; ZINC1730183; NSC179487; NSC-179487; AS-58877; W19548; 1,3-Benzenediol, 2(or 5)-butyl-5(or 2)-phenyl-; NCGC00384855-01!2-butyl-5-pentylbenzene-1,3-diol
|
|
CAS | 50982-33-7 | |
PubChem CID | 170949 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 236.35 | ALogp: | 5.5 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 40.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 17 | QED Weighted: | 0.67 |
Caco-2 Permeability: | -4.799 | MDCK Permeability: | 0.00001810 |
Pgp-inhibitor: | 0.26 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.278 | Plasma Protein Binding (PPB): | 97.69% |
Volume Distribution (VD): | 2.555 | Fu: | 1.95% |
CYP1A2-inhibitor: | 0.958 | CYP1A2-substrate: | 0.812 |
CYP2C19-inhibitor: | 0.852 | CYP2C19-substrate: | 0.208 |
CYP2C9-inhibitor: | 0.469 | CYP2C9-substrate: | 0.948 |
CYP2D6-inhibitor: | 0.874 | CYP2D6-substrate: | 0.861 |
CYP3A4-inhibitor: | 0.259 | CYP3A4-substrate: | 0.132 |
Clearance (CL): | 8.92 | Half-life (T1/2): | 0.666 |
hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.057 |
Drug-inuced Liver Injury (DILI): | 0.027 | AMES Toxicity: | 0.147 |
Rat Oral Acute Toxicity: | 0.125 | Maximum Recommended Daily Dose: | 0.127 |
Skin Sensitization: | 0.942 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.607 | Eye Irritation: | 0.967 |
Respiratory Toxicity: | 0.461 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002935 | 0.478 | D0O1UZ | 0.429 | ||||
ENC003812 | 0.446 | D0P1FO | 0.354 | ||||
ENC003811 | 0.446 | D07UHS | 0.313 | ||||
ENC001436 | 0.429 | D0T7OW | 0.283 | ||||
ENC000863 | 0.427 | D0V7XF | 0.281 | ||||
ENC004818 | 0.421 | D06KYN | 0.273 | ||||
ENC004665 | 0.405 | D04VKS | 0.262 | ||||
ENC004248 | 0.385 | D0L7AS | 0.260 | ||||
ENC002055 | 0.375 | D0Y6KO | 0.257 | ||||
ENC004625 | 0.371 | D06ORU | 0.253 |